Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

CUSIP: 984241109

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
45,101,565
Total 13F shares
21,284,113
Share change
+1,222,798
Total reported value
$919,504,408
Price per share
$43.20
Number of holders
108
Value change
+$53,403,136
Number of buys
73
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 984241109?
CUSIP 984241109 identifies YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q2 2020

As of 30 Jun 2020, Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,284,113 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Sofinnova Investments, Inc., Cormorant Asset Management, LP, FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., LOOMIS SAYLES & CO L P, and Artisan Partners Limited Partnership. This page lists 108 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.